Company Filing History:
Years Active: 2017-2019
Title: Inventor David Melodelima: Advancing Ultrasound Technology
Introduction
David Melodelima, an inventive mind from Ruy, France, has made significant contributions to the field of ultrasound technology. With a total of three patents to his name, his work focuses on enhancing medical imaging and treatment methodologies through innovative techniques.
Latest Patents
Among Melodelima's notable inventions is a **Method for Characterising an Ultrasound Wound in Organic Tissues**. This method involves characterizing ultrasound lesions created by applying high-intensity focused ultrasound. The process includes acquiring characterization images of organic tissues after a minimum of two days post-ultrasound application, detecting the presence of a contrast border in these images, and determining the lesion's extent based on this border.
Another significant patent is the **Method and Apparatus for Generating Focused Ultrasonic Waves with Surface Modulation**. This invention relates to generating ultrasonic waves that are focused on a particular focal zone to facilitate biological lesions, utilizing multiple ultrasonic transducer elements to activate these waves effectively.
Career Highlights
Throughout his career, David Melodelima has been associated with well-known organizations, including Edap Tms France and Inserm (Institut National de la Santé et de la Recherche Médicale). His work at these institutions has enabled him to explore the depths of ultrasound technology and contribute to medical advancements.
Collaborations
Melodelima's journey in innovation has also involved collaborations with other professionals in the field, notably Jeremy Vincenot and Emmanuel Blanc. Their joint efforts have enriched research and development in ultrasound applications, paving the way for future discoveries.
Conclusion
David Melodelima stands out as a prominent inventor with groundbreaking patents that push the boundaries of ultrasound technology. His ongoing commitment to innovation and collaboration is expected to lead to further advancements in medical imaging and treatment techniques.